Pharmacokinetics and Bioequiavailability of Levofloxacin Tablets in Healthy Volunteers
Yan Yong-ya
Abstract
Yan Yong-ya
Abstract
OBJECTIVE: To study the pharmacokinetics and bioequiavailability of 2 kinds of levofloxacin tablets in healthy volunteers.METHODS: A single dose of test and reference tablets of levofloxacin were given to 20 healthy male volunteers in a randomized cross-over study.Plasma level of levofloxacin were detected by HPLC and the pharmacokinetic parameters and bioequiavailability of 2 kinds of levofloxacin tablets were computed.RESULTS: The main pharmacokinetic parameters of the test and the reference preparations were as follows: Cmax were(6.54±1.39) mg·L-1 and(6.31±1.21) mg·L-1;tmax were(1.04±0.39)h and(1.04±0.40)h;t1/2 were(7.77±0.84)h and(7.98±1.30)h;AUC0~24 were(50.66±5.84) mg·h·L-1 and(50.94±4.82) mg·h·L-1;AUC0~∞ were(57.55±6.75) mg·h·L-1 and(58.42±6.40) mg·h·L-1,respectively.Estimated by AUC0~24,the relative bioavailability of the test preparation was(100.20±14.23)%.CONCLUSION: The result of statistical analysis showed that test and the reference tablets of levofloxacin were bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To study the pharmacokinetics and bioequiavailability of 2 kinds of levofloxacin tablets in healthy volunteers.METHODS: A single dose of test and reference tablets of levofloxacin were given to 20 healthy male volunteers in a randomized cross-over study.Plasma level of levofloxacin were detected by HPLC and the pharmacokinetic parameters and bioequiavailability of 2 kinds of levofloxacin tablets were computed.RESULTS: The main pharmacokinetic parameters of the test and the reference preparations were as follows: Cmax were(6.54±1.39) mg·L-1 and(6.31±1.21) mg·L-1;tmax were(1.04±0.39)h and(1.04±0.40)h;t1/2 were(7.77±0.84)h and(7.98±1.30)h;AUC0~24 were(50.66±5.84) mg·h·L-1 and(50.94±4.82) mg·h·L-1;AUC0~∞ were(57.55±6.75) mg·h·L-1 and(58.42±6.40) mg·h·L-1,respectively.Estimated by AUC0~24,the relative bioavailability of the test preparation was(100.20±14.23)%.CONCLUSION: The result of statistical analysis showed that test and the reference tablets of levofloxacin were bioequivalent.
Key concepts: Levofloxacin, Bioequivalence, Pharmacokinetics, Cmax, Bioavailability, Pharmacology, Medicine, High-performance liquid chromatography